Stocktoria
Axil Brands, Inc. AXIL
Axil Brands, Inc. (AXIL) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $26.3M at a 3.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.528 |
| Retained earnings / assets | 0.056 |
| EBIT / assets | 0.09 |
| Equity / liabilities | 3.009 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AXIL | Axil Brands, Inc. | 6/9 | 7.41 | 51.2 | -4.5% |
| UG | UNITED GUARDIAN INC | 4/9 | 15.38 | 15.7 | -13.4% |
| PTNM | Pitanium Ltd | 2/9 | 2.33 | — | -88.7% |
| BNKK | BONK, INC. | 4/9 | — | — | — |
| SHFH | Scientist Home Future Health Ltd | — | -3.67 | — | — |
| CABR | Caring Brands, Inc. | 2/9 | -11.76 | — | — |
| SLSN | SOLESENCE, INC. | 3/9 | -3.7 | 32.6 | +18.6% |
About Axil Brands, Inc.
AXIL Brands, Inc. engages in the manufacture, marketing, distribution, and sale of hearing and audio enhancement and protection products in the United States, Canada, Europe, Australia, New Zealand, Africa, and Asia. The company operates through Hearing Enhancement and Protection, and Hair and Skin Care segments. It provides ear plugs, earmuffs, ear buds, and outdoor speakers under the AXIL brand. The company also provides shampoo, conditioner, scalp treatments, styling aids, and skin health solutions under the Reviv3 Procare brand, as well as cleansing, conditioning, repair, protection, and volume enhancement products. It sells GS Extreme, a Bluetooth-enabled earbuds for sound enhancement and hearing protection; XCOR True Wireless, a Digital earbud with touch control; TRACKR Blu, a Bluetooth audio earmuffs with advanced sound enhancement and protection; and X-PRO, a passive ear protections. The company sells its products through direct-to-consumer e-commerce channels, various third-party online platforms, distributors, and salon partnerships. It serves the sporting goods, recreational, military, federal agent, law enforcement, tactical, and industrial sectors. The company was formerly known as Reviv3 Procare Company and changed its name to AXIL Brands, Inc. in February 2024. AXIL Brands, Inc. was incorporated in 2015 and is headquartered in Beverly Hills, California.
FAQ
Is AXIL financially healthy?
Axil Brands, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does AXIL pay a dividend?
No, Axil Brands, Inc. does not currently pay a dividend.
How profitable is AXIL?
In FY2025, Axil Brands, Inc. had a net margin of 3.3% and a return on equity of 8.9%.
What is AXIL's P/E ratio?
Axil Brands, Inc.'s trailing price-to-earnings (P/E) ratio is about 51.2×, based on its latest annual earnings.
What is the analyst price target for AXIL?
The average Wall-Street price target for Axil Brands, Inc. is $14.25, about 159.1% above the recent price, from 1 analysts.
Is AXIL a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Axil Brands, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 51.2×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.